Similarly, a study of 80 patients with advanced, inoperable bladder cancer undergoing second line MVAC chemotherapy concurred that patients whose CRP normalized after chemotherapy also had improved overall survival as compared to the non-normalized group. This evidence concerns the gene CRP and urinary bladder carcinoma.